Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
31.49
-0.21 (-0.66%)
May 14, 2026, 11:47 AM EDT - Market open
Viking Therapeutics Employees
Viking Therapeutics had 59 employees as of March 31, 2026. The number of employees increased by 13 or 28.26% compared to the same quarter last year.
Employees
59
Change
13
Growth
28.26%
Revenue / Employee
n/a
Profits / Employee
-$8,005,678
Market Cap
3.66B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Arcus Biosciences | 601 |
| Crinetics Pharmaceuticals | 594 |
| Beam Therapeutics | 522 |
| Travere Therapeutics | 497 |
| Catalyst Pharmaceuticals | 182 |
| Edgewise Therapeutics | 154 |
VKTX News
- 2 days ago - Viking Therapeutics’ VK2735 demonstrates wieght loss in Phase 2 trial - TheFly
- 2 days ago - Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026 - PRNewsWire
- 9 days ago - Viking Therapeutics Announces Two Poster Presentations at European Congress on Obesity (ECO) 2026 - PRNewsWire
- 9 days ago - Viking Therapeutics call volume above normal and directionally bullish - TheFly
- 13 days ago - Viking Therapeutics price target lowered to $100 from $105 at Cantor Fitzgerald - TheFly
- 14 days ago - Viking Therapeutics price target lowered to $95 from $99 at Morgan Stanley - TheFly
- 14 days ago - Viking Therapeutics reports Q1 EPS ($1.37), consensus (91c) - TheFly
- 14 days ago - Viking Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts